Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Predictors of Arsenic and Breast Cancer Risk

EF 2018-19

Résumé
Arsenic is a bona fide carcinogen; however, data linking arsenic exposure and breast cancer is inconclusive. Human exposure to this metallic element can originate from many sources, such as specific occupations (e.g., working within a mine), consumption of contaminated food (e.g., rice), or ingestion of contaminated water (e.g., well water). In a large prospective study of 1,702 Polish women, our team recently reported a significant 12- fold increased risk of breast cancer among women with the highest quartile of total circulating blood arsenic (HR Q4 vs. ref.= 12.72; 95%CI 3.89-41.57, P trend < 0.0001). This strong, dose-dependent finding suggests that blood arsenic status is a strong predictor for breast cancer, underscoring the importance of identifying potential sources of arsenic exposure. Thus, the overall study goal is to (1) identify predictors of circulating blood arsenic and (2) determine any trends in the variation of arsenic levels (and its intermediates) between people. To fulfill these objectives, a cross-sectional, prospective investigation will be conducted with the 1,702 women in the pre-existing Polish cohort. Each will be asked to complete a study-specific questionnaire, identifying common sources of arsenic, and provide a venous blood sample. Inductively coupled plasma mass spectroscopy will determine total blood arsenic levels and high-performance liquid chromatography will indicate levels of metabolic intermediates. Multivariate regression will be used to evaluate the predictors of arsenic in the blood and breast cancer risk. These results will identify the predictors of circulating total blood arsenic, indicating an important time point for intervention and potential population health strategies to reduce the risk of breast cancer incidence.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
411286
Name
Pullella Katherine
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Predictors of Arsenic and Breast Cancer Risk
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Arsenic; Breast Cancer; Diet; Environmental Carcinogen; Exposure; Intervention; Modifiable Risk Factors; Risk; Water
Abstract
Arsenic is a bona fide carcinogen; however, data linking arsenic exposure and breast cancer is inconclusive. Human exposure to this metallic element can originate from many sources, such as specific occupations (e.g., working within a mine), consumption of contaminated food (e.g., rice), or ingestion of contaminated water (e.g., well water). In a large prospective study of 1,702 Polish women, our team recently reported a significant 12- fold increased risk of breast cancer among women with the highest quartile of total circulating blood arsenic (HR Q4 vs. ref.= 12.72; 95%CI 3.89-41.57, P trend < 0.0001). This strong, dose-dependent finding suggests that blood arsenic status is a strong predictor for breast cancer, underscoring the importance of identifying potential sources of arsenic exposure. Thus, the overall study goal is to (1) identify predictors of circulating blood arsenic and (2) determine any trends in the variation of arsenic levels (and its intermediates) between people. To fulfill these objectives, a cross-sectional, prospective investigation will be conducted with the 1,702 women in the pre-existing Polish cohort. Each will be asked to complete a study-specific questionnaire, identifying common sources of arsenic, and provide a venous blood sample. Inductively coupled plasma mass spectroscopy will determine total blood arsenic levels and high-performance liquid chromatography will indicate levels of metabolic intermediates. Multivariate regression will be used to evaluate the predictors of arsenic in the blood and breast cancer risk. These results will identify the predictors of circulating total blood arsenic, indicating an important time point for intervention and potential population health strategies to reduce the risk of breast cancer incidence.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Pullella, Katherine
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~